Mingzhu Liu1, Jinying Jia1, Xinjie Wang1, Yanjie Liu2, Chunfang Wang2, Ruitai Fan3. 1. a Department of Integrated Traditional Chinese and Western Medicine , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , China. 2. b Department of Gynecology , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , China. 3. c Department of Radiotherapy , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , China.
Abstract
BACKGROUND: HOX transcript antisense RNA (HOTAIR) is a long non-coding RNA (lncRNA) widely involved in the progression of numerous malignancies. Whereas, the potential molecular mechanism of HOTAIR involved in cervical cancer progression is still needed to be elaborated. METHODS: The expression of HOTAIR and miR-143-3p were detected in cervical cancer tissues and cells by qRT-PCR. MTT and flow cytometry analysis were performed to measure cell proliferation and apoptosis. Bioinformatics, Dual-Luciferase reporter and RIP were used to analyze the possible correlation between HOTAIR, miR-143-3p and BCL2. The expression of Bax and BCL2 was detected by western blot. Mice xenograft model was established to confirm the role of HOTAIR on tumor growth in vivo. RESULTS: HOTAIR expression was elevated while miR-143-3p expression was reduced in cervical cancer tissues and cell lines. HOTAIR knockdown suppressed proliferation and enhanced apoptosis in cervical cancer cells. Moreover, HOTAIR could function as a sponge for miR-143-3p. The inhibitory effect of HOTAIR knockdown on cervical cancer cells growth was abolished following decrease of miR-143-3p expression. Furthermore, HOTAIR promoted BCL2 expression by modulating miR-143-3p. BCL2 overexpression attenuated the tumor-suppressive effect of miR-143-3p in cervical cancer. Finally, the carcinogenicity of HOTAIR was validated in mice. CONCLUSIONS: HOTAIR promoted cervical cancer cell growth by modulating BCL2 via miR-143-3p, hinting a novel regulatory mechanism and potential therapeutic target in cervical cancer.
BACKGROUND: HOX transcript antisense RNA (HOTAIR) is a long non-coding RNA (lncRNA) widely involved in the progression of numerous malignancies. Whereas, the potential molecular mechanism of HOTAIR involved in cervical cancer progression is still needed to be elaborated. METHODS: The expression of HOTAIR and miR-143-3p were detected in cervical cancer tissues and cells by qRT-PCR. MTT and flow cytometry analysis were performed to measure cell proliferation and apoptosis. Bioinformatics, Dual-Luciferase reporter and RIP were used to analyze the possible correlation between HOTAIR, miR-143-3p and BCL2. The expression of Bax and BCL2 was detected by western blot. Mice xenograft model was established to confirm the role of HOTAIR on tumor growth in vivo. RESULTS:HOTAIR expression was elevated while miR-143-3p expression was reduced in cervical cancer tissues and cell lines. HOTAIR knockdown suppressed proliferation and enhanced apoptosis in cervical cancer cells. Moreover, HOTAIR could function as a sponge for miR-143-3p. The inhibitory effect of HOTAIR knockdown on cervical cancer cells growth was abolished following decrease of miR-143-3p expression. Furthermore, HOTAIR promoted BCL2 expression by modulating miR-143-3p. BCL2 overexpression attenuated the tumor-suppressive effect of miR-143-3p in cervical cancer. Finally, the carcinogenicity of HOTAIR was validated in mice. CONCLUSIONS:HOTAIR promoted cervical cancer cell growth by modulating BCL2 via miR-143-3p, hinting a novel regulatory mechanism and potential therapeutic target in cervical cancer.
Authors: Maartje G Noordhuis; Rudolf S N Fehrmann; G Bea A Wisman; Esther R Nijhuis; Jelmer J van Zanden; Perry D Moerland; Emiel Ver Loren van Themaat; Haukeline H Volders; Mirjam Kok; Klaske A ten Hoor; Harry Hollema; Elisabeth G E de Vries; Geertruida H de Bock; Ate G J van der Zee; Ed Schuuring Journal: Clin Cancer Res Date: 2011-03-08 Impact factor: 12.531
Authors: Jennifer Y Tan; Tamara Sirey; Frantisek Honti; Bryony Graham; Allison Piovesan; Matthias Merkenschlager; Caleb Webber; Chris P Ponting; Ana C Marques Journal: Genome Res Date: 2015-03-19 Impact factor: 9.043
Authors: Maria Lee; Hee Jung Kim; Sang Wun Kim; Sun-Ae Park; Kyung-Hee Chun; Nam Hoon Cho; Yong Sang Song; Young Tae Kim Journal: Oncotarget Date: 2016-07-12